ÿÄêµÄ5ÔÂ19ÈÕÊÇÌìÏÂÑ×Ö¢ÐÔ³¦²¡ÈÕ£¬ÈÃÎÒÃÇÒ»Æð¹Ø×¢ÕâÖÖ²»¿ÉÖÎÓú¡¢ÐèÒªºã¾ÃÖÎÁƵļ²²¡¡£
Ñ×Ö¢ÐÔ³¦²¡ÈÅÂÒ»¼ÕßÕý³£ÉúÑÄ Ñ×Ö¢ÐÔ³¦²¡£¨Inflammatory Bowel Disease, IBD£©ÊÇÒ»ÖÖÂýÐÔ¡¢·ÇÌØÒìÐԵij¦µÀÑ×Ö¢ÐÔ¼²²¡£¬Ö÷Òª°üÀ¨¿ËÂÞ¶÷²¡£¨Crohn¡¯s Disease, CD£©ºÍÀ£ÑñÐԽ᳦Ñ×£¨Ulcerative Colitis, UC£©Á½Àà¡£ ¾ÝÈ«ÇòÎÀÉú×éÖ¯£¨WHO£©Êý¾ÝÏÔʾ£¬IBDÔÚÅ¹ú¼ÒÖеķ¢²¡Âʽϸߣ¬Ïà±È֮ϣ¬Éú³¤Öйú¼ÒµÄ²¡Àý½ÏÉÙ¡£µ«ÖµµÃ×¢ÖصÄÊÇ£¬½üÄêÀ´£¬Ëæ×ÅÉúÑÄ·½·¨¡¢Òûʳ½á¹¹¼°ÇéÐÎÒòËصÄת±ä£¬Éú³¤Öйú¼ÒµÄIBD»¼²¡ÂÊÒ²³ÊÉÏÉýÇ÷ÊÆ¡£ ¿ËÂÞ¶÷²¡¿ÉÓ°ÏìËùÓÐÄêËê¶ÎÈËȺ£¬µ«Í¨³£ÔÚ¶ùͯºÍÄêÇáÈË£¨10¡ª30Ë꣩ʱÆÚÊ״ηºÆð¡£À£ÑñÐԽ᳦Ñ׸üÇãÏòÓÚÈÅÂÒÄêÇá³ÉÈË£¨15Ëꡪ30Ë꣩ºÍÖÐÍíÄêȺÌ壨50Ëꡪ70Ë꣩£¬ÔÚ¶ùͯÖеı¬·¢ÂʵÍÓÚ¿ËÂÞ¶÷²¡¡£ ƵÈÔµÄÈç²ÞÐèÇó¡¢Ìض¨Ê³Îï²»ÄÍÊÜ¡¢ÌåÖØϽµ¡¢ÑªÐé¼°Ò»Á¬Æ£À͵ÈÖ¢×´ÑÏÖØÏÞÖÆÁËIBD»¼ÕßµÄÌåÁ¦ºÍ»î¶¯ÄÜÁ¦£¬½ø¶øÓ°Ïìµ½Éç½»»¥¶¯ºÍÖ°ÒµÉú³¤£¬µ¼Ö»¼ÕßÔâÊÜÖØ´óµÄÐÄÀí¼°ÐÄÀíѹÁ¦¡£
Ñ×Ö¢ÐÔ³¦²¡ÉÐÎÞ·¨¸ùÖÎ Ö»¹ÜIBDÏÖÔÚÉÐÎÞ¸ùÖÎÖ®·¨£¬µ«ÏÖ´úÒ½ÁÆÄÜ×ÊÖú»¼Õß»º½âÖ¢×´£¬ÖÎÁÆÖ¼Ôڸ濢ÁÙ´²»º½âÓ볦µÀð¤Ä¤ÓúºÏ£¬Í¬Ê±¿ØÖƲ¢·¢Ö¢¡¢¼õ»º²¡ÇéÏ£Íû£¬²¢Î¬³Öºã¾ÃÎȹ̡£ÖÎÁÆÊֶΰüÀ¨Ò©ÎïÖÎÁÆ¡¢¸öÐÔ»¯ÓªÑøÍýÏë¡¢ÐëҪʱµÄÊÖÊõ½éÈ룬ÒÔ¼°ÉúÑÄ·½·¨µ÷½âµÈ¶àÔª»¯Õ½ÂÔ¡£ ¡¶Ñ×Ö¢ÐÔ³¦²¡Õï¶ÏÓëÖÎÁƵĹ²Ê¶Òâ¼û¡·ÖÐÇ¿µ÷£¬ÒÀ¾Ý»¼ÕßÏêϸ²¡Ç鶨ÖƼƻ®¡£ÁÙ´²Ò½Éú»á˼Á¿¼²²¡»î¶¯¶È¡¢²¡±ä¹æÄ£¼°ÀàÐÍ£¨¿ËÂÞ¶÷²¡»òÀ£ÑñÐԽ᳦Ñ×£©£¬À´¾«×¼Ñ¡ÔñÖÎÁÆ·½·¨¡£Òò´Ë£¬°´ÆÚÆÀ¹À²¡Ç飬ÎÞаµ÷½âÖÎÁÆ£¬¹ØÓÚά³ÖIBDÖÎÁÆЧ¹ûºÍÔ¤·À¸´·¢ÖÁ¹ØÖ÷Òª¡£
ANCAºÍASCAÊǸ¨ÖúÕï¶ÏIBDµÄÒªº¦Ö¸±ê IBDµÄÕï¶Ïȱ·¦¼òµ¥½ð±ê×¼£¬ÐèÒª×ÛºÏÁÙ´²ÌåÏÖ¡¢ÊµÑéÊÒ¼ì²é¡¢Ó°Ïñѧ¡¢ÄÚ¾µ¼ì²éºÍ×éÖ¯²¡ÀíѧЧ¹û¡£Í¬Ê±£¬ÎªÁË׼ȷÇø·ÖIBDÓëÆäËûÀàËƼ²²¡£¬ÈçѬȾÐÔ³¦Ñ×»ò³¦½áºË£¬ÅбðÕï¶ÏÊDZز»¿ÉÉٵİ취¡£ ½üÄêÀ´£¬ÑªÇåѧ±ê¼ÇÎï¼ì²âÒÔÆäÇáÓ¯¡¢ÎÞÍ´¡¢»¼ÕßÒ×½ÓÊܵÄÌص㣬³ÉΪ¸¨ÖúÕï¶ÏµÄÖ÷Òª¹¤¾ß£¬ÓÈÆäÔÚÁÙ´²ÌåÏÖ²»µä·¶µÄÇéÐÎÏ¡£ÆäÖУ¬Á½Ïî±ê¼ÇÎ¡ª¿¹ÖÐÐÔÁ£Ï¸°û°û½¬¿¹Ì壨ANCA£©ºÍ¿¹Äð¾Æ½Íĸ¿¹Ì壨ASCA£©¡ª¡ªÒѱ»ÌìÏÂ賦×éÖ¯ÈÏ¿É£¬×÷Ϊ¸¨ÖúÕï¶ÏIBDµÄÖ¸±ê¡£ ANCA³£ÓëÀ£ÑñÐԽ᳦Ñ×£¨UC£©¹ØÁª£¬Ñо¿ÏÔʾ£¬UC»¼ÕßÖÐANCAÑôÐÔÂʸߴï40%ÖÁ85%£¬¶ø¿ËÂÞ¶÷²¡£¨CD£©»¼Õß½ö5%ÖÁ10%£¬¿µ½¡ÈËÔò¸üµÍ¡£×÷ΪUCµÄ¸¨ÖúÕï¶Ï¹¤¾ß£¬ANCAÕ¹ÏÖ³öÁË50.4%µÄÕï¶ÏÃô¸Ð¶ÈºÍ94.4%µÄÌØÒì¶È[3]¡£ ASCAÓë¿ËÂÞ¶÷²¡¹Øϵ¸üÇ×½ü£¬Ô¼50%ÖÁ65%µÄCD»¼Õß³ÊÑôÐÔ£¬¶øUC»¼ÕßÑôÐÔÂʽö6%ÖÁ12%¡£ASCAÔÚCDÕï¶ÏÖеÄÃô¸Ð¶ÈΪ34.7%£¬ÌØÒì¶È´ï89.7%[3]£¬ÊǸ¨ÖúÇø·ÖUCºÍCDµÄÓÐÁ¦ÖúÊÖ¡£
¡°¾«×¼ÕïÁÆ£«¿Æѧ¹ÜÀí¡±Ó¦¶ÔIBD´øÀ´µÄºã¾Ã¿µ½¡ÌôÕ½
Ó¦¶ÔIBD´øÀ´µÄºã¾Ã¿µ½¡ÌôÕ½£¬¾«×¼Õï¶ÏÊÇÓÐÓÃÖÎÁƵÄÌõ¼þ¡£mg±ùÇòÍ»ÆƹÙÍøÍøÕ¾ÌṩÁ˶àÏîÕë¶ÔÐԵļì²â·þÎñ£¬×ÊÖúÁÙ´²Ò½Éú¸ü׼ȷµØÕÆÎÕ»¼Õß²¡Ç飬ΪºóÐøÖÎÁÆÌṩ¿ÆѧÒÀ¾Ý¡£
¿¹ÖÐÐÔÁ£Ï¸°û°û½¬¿¹ÌåÁ½Ïî
°üÀ¨p-ANCAºÍc-ANCA£¬¶ÔÅбðÕï¶ÏUCµÈÓÐÖ÷Òª¼ÛÖµ¡£
賦µÀ²¡×ÔÉí¿¹ÌåÎåÏî
º¸ÇASCA¡¢¿¹Âó½ºÂѰ׿¹Ì壨AGA£©¡¢¿¹×éÖ¯Ð͹Ȱ±Ë᰷תÒÆø¿¹Ì壨tTG£©¡¢¿¹ÄÚÒò×Ó¿¹Ì壨IFA£©¡¢¿¹±Úϸ°û¿¹Ì壨PCA£©£¬ÆÕ±éÓ¦ÓÃÓÚIBD¼°ÆäËû賦µÀ¼²²¡µÄÅбðÓë¼à²â¡£
ͬʱ£¬Æð¾¢µÄÉúÑÄ̬¶ÈºÍ¿Æѧ¹ÜÀí£¬Ò²ÄÜ×ÊÖú»¼Õ߸ÄÉÆÉúÑÄÖÊÁ¿¡£ ×ñÕÕÒ½Öö£ºÑÏ¿á°´Ò½ÉúÖ¸µ¼ÓÃÒ©£¬²»ËæÒâ±ä»»ÖÎÁƼƻ®¡£ Òûʳ¹ÜÀí£ºÓëÓªÑøʦºÏ×÷£¬¶¨ÖƸöÐÔ»¯Òûʳ£¬×¢ÖØʳÎï²»ÄÍÊÜɸ²é¡£ ÐÄÀíÓëÔ˶¯£º¼á³ÖÁ¼Ê¢Òâ̬£¬ÊÊÁ¿Ô˶¯£¬ÔöÇ¿ÉíÌå¶Ô¿¹Á¦¡£ °´ÆÚËæ·Ã£ºÓëÒ½Éú¼á³ÖÏàͬ£¬¼ÓÈ뻼Õß½ÌÓý»î¶¯£¬Ç×½ü¼à²â²¡Çéת±ä¡£
²Î¿¼ÎÄÏ× [1] Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, Gearry R, Goh KL, Hamid S, Khan AG. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2010;16:112-124 [2] Ñ×Ö¢ÐÔ³¦²¡Õï¶ÏÓëÖÎÁƵĹ²Ê¶Òâ¼û£¨2018Äꡤ±±¾©£©ÖлªÑ×ÐÔ³¦²¡ÔÓÖ¾ 2018 Äê 7 ÔÂµÚ 2 ¾íµÚ 3 ÆÚ Chin J Inflamm Bowel Dis£¬July 2018£¬Vol.2£¬No.3 [3] ÌÆò«,Ì·Ýí,Éò±ù±ù,µÈ. ²î±ðѪÇåѧ±ê¼ÇÎïÔÚÑ×Ö¢ÐÔ³¦²¡ÖеÄÕï¶Ï¼ÛÖµÒÔ¼°Óë¼²²¡±íÐ͵ĹØÁªÆÊÎö[J]. ÖлªÒ½Ñ§ÔÓÖ¾,2022,102(47):3743-3748.